longer
time
diagnosi
definit
surgeri
ttd
associ
increas
melanomaspecif
mortal
studi
black
patient
longer
ttd
melanoma
control
sociodemograph
factor
differ
persist
insur
stage
iiii
melanoma
time
immunotherapi
target
intervent
improv
ttd
black
melanoma
patient
import
improv
outcom
abstract
background
longer
time
diagnosi
definit
surgeri
ttd
associ
increas
melanomaspecif
mortal
although
black
patient
present
later
stage
melanoma
wors
surviv
nonhispan
white
nhw
patient
associ
race
ttd
unknown
object
investig
racial
differ
time
melanoma
treatment
method
retrospect
review
nation
cancer
databas
multivari
logist
regress
use
evalu
associ
race
ttd
control
sociodemographicdiseas
characterist
melanoma
patient
identifi
black
black
patient
longer
ttd
stage
iiii
melanoma
p
time
immunotherapi
ttd
stage
iv
melanoma
time
chemotherapi
p
control
sociodemograph
characterist
black
patient
twice
odd
ttd
day
three
time
odd
ttd
day
five
time
odd
ttd
day
racial
differ
ttd
persist
within
insur
type
patient
medicaid
longest
ttd
mean
day
privat
insur
shortest
ttd
mean
day
p
conclus
target
approach
improv
ttd
black
patient
integr
reduc
racial
dispar
melanoma
outcom
estim
american
diagnos
cutan
melanoma
annual
nation
incid
cutan
melanoma
continu
rise
past
decad
shown
dermatolog
visit
reduc
advers
event
mortal
unnecessari
hospit
melanoma
patient
howev
substanti
dispar
access
util
dermatolog
care
melanoma
patient
demonstr
myriad
clinic
sociodemograph
factor
includ
age
sex
rural
provid
suppli
distanc
dermatolog
care
poverti
rate
specif
race
insur
statu
associ
differ
diseasespecif
mortal
melanoma
patient
black
patient
present
later
stage
melanoma
later
stage
melanoma
diagnosi
increas
time
treatment
stage
melanoma
independ
associ
increas
melanomaspecif
mortal
despit
associ
race
time
diagnosi
definit
surgeri
ttd
unknown
primari
goal
investig
differ
ttd
black
nonhispan
white
nhw
melanoma
patient
secondari
goal
determin
differ
ttd
black
nhw
patient
melanoma
stage
insur
type
examin
racial
differ
stage
present
distanc
hospit
time
medic
treatment
immunotherapi
chemotherapi
patient
cutan
melanoma
identifi
use
nation
cancer
databas
committe
cancer
ajcc
patholog
stage
iiv
cutan
melanoma
includ
studi
ttd
calcul
number
day
initi
diagnosi
definit
surgic
resect
primari
tumor
patient
miss
data
covari
unknown
stage
excision
biopsi
definit
treatment
ttd
zero
day
exclud
descript
analys
perform
initi
univari
comparison
sociodemograph
characterist
racial
group
use
pearson
chisquar
analysi
varianc
anova
student
ttest
pool
initi
use
univari
comparison
time
immunotherapi
chemotherapi
well
ttd
stratifi
stage
insur
type
racial
group
multivari
logist
regress
use
evalu
associ
race
ttd
control
sex
age
median
household
incom
insur
type
multivari
model
adjust
odd
ratio
calcul
black
patient
refer
group
nonhispan
white
institut
review
board
approv
requir
use
publicli
avail
deidentifi
databas
analys
perform
statist
softwar
r
p
consid
signific
tabl
studi
black
patient
greater
ttd
stage
iiii
melanoma
greater
time
immunotherapi
compar
nhw
patient
racial
differ
ttd
persist
within
insur
type
racial
differ
ttd
stage
iv
melanoma
time
chemotherapi
addit
compar
nhw
patient
black
patient
twice
odd
ttd
day
three
time
odd
ttd
day
five
time
odd
ttd
day
find
add
literatur
demonstr
increas
ttd
black
patient
melanoma
control
sex
age
incom
insur
type
data
suggest
increas
ttd
black
patient
melanoma
may
independ
explanatori
factor
racial
differ
melanoma
surviv
alongsid
factor
later
stage
present
biolog
differ
melanoma
characterist
differ
healthcar
util
multipl
unfavor
socioeconom
factor
may
exacerb
overal
health
statu
addit
effect
individu
factor
racial
differ
ttd
persist
within
insur
group
impli
insur
statu
fulli
account
racial
ttd
dispar
found
black
patient
also
increas
ttd
despit
live
closer
hospit
suggest
physic
distanc
hospit
much
contributor
ttd
melanoma
cancer
eg
colorect
recent
studi
three
highrisk
surgic
procedur
show
black
patient
live
closer
highqual
hospit
like
receiv
surgeri
lowqual
hospit
nhw
patient
possibl
similar
phenomenon
exist
ttd
melanoma
qualiti
avail
melanoma
treatment
may
thu
significantli
differ
racial
group
reason
travel
burden
abbrevi
ttd
time
definit
surgic
treatment
nhw
nonhispan
white
sd
standard
deviat
abbrevi
ttd
time
definit
surgic
treatment
nhw
nonhispan
white
sd
standard
deviat
abbrevi
ci
confid
interv
